Actively Recruiting
A Prospective Multicenter Registry Study on BASIS Technique for Endovascular Therapy of Acute Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic Disease
Led by Fujian Medical University Union Hospital · Updated on 2025-03-18
250
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
Sponsors
F
Fujian Medical University Union Hospital
Lead Sponsor
Z
Zhangzhou Municipal Hospital of Fujian Province
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will explore the safety and efficacy of BASIS technology in ICAS-LVO lesions through a multicenter, prospective, registry, observational single-arm study.By registering intraoperative recanalization using this technique time, recanalization grade, operative thrombectomy times, intraoperative complications perforating branch occlusion, vascular dissection, vascular rupture, Ectopic thrombus, probability of symptomatic intracranial hemorrhage, mRS Score and mortality rate were followed up for 3 months The unique advantages of the application of the assessment BASIS in this type of lesion provide new insights into complex lesions such as ICAS-LVO The thought and operation method can shorten the operation time, improve the good prognosis, reduce the economic burden and reduce the operation Complications make a positive contribution to ensure that patients receive safe, effective and precise treatment.
CONDITIONS
Official Title
A Prospective Multicenter Registry Study on BASIS Technique for Endovascular Therapy of Acute Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of ischemic stroke
- Stroke symptoms started within 72 hours before the visit, including wake-up or unknown time strokes
- Neuroimaging shows occlusion of large anterior or posterior intracranial vessels with large atherosclerosis type
- BASIS technique used for intravascular treatment
You will not qualify if you...
- Acute occlusion of multiple vessels or tandem lesions on neuroimaging at admission
- History of atrial fibrillation or heart valve surgery
- Contraindications to antiplatelet drugs such as hemophilia or thrombocytopenia
- Rare diseases or known coagulation or platelet disorders
- Active internal bleeding, history of intracranial bleeding, arteriovenous malformation, or aneurysm
- Other stroke types including hemorrhagic stroke
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here